IL33 and asthma: Administration of IL-33 to mice induces airway inflammation independently of adaptive immune responses,1 whereas increased levels of expression of IL-33 in bronchial epithelia are associated with increased severity of disease in asthmatic patients.2-4 An understanding of the mechanisms and cellular targets of IL-33 might therefore lead to therapeutic intervention in patients with asthma and allergic inflammation.5